EMILY SPANGLER: Open Payments
NPI 1174026884 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 14 payments from 10 companies in 2025. Trend: 2023 $265 · 2024 $259 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $58 |
| Lilly USA, LLC | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Organon LLC | 1 | $30 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $29 |
| BSN Medical Inc | 1 | $25 |
| ABBVIE INC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| CooperSurgical, Inc. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $15 |
Products named: Veozah, Mirena, NEXPLANON, CUTIMED, ZEPBOUND, MOUNJARO, LILETTA, Wegovy.
Industry payments across FL — which companies pay providers there.
